Investigational Three-Month TB Regimen Is Safe But Ineffective, NIH Study Finds

 July 5, 2023 -- The first clinical trial of a three-month tuberculosis (TB) treatment regimen is closing enrollment because of a high rate of unfavorable outcomes with the investigational course of treatment. AIDS Clinical Trials Group 5362,...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials